S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
The craze for Masters gnomes is growing. Little golf-centric statue is now a coveted collector item
Olympic track uniforms spark online debate about who designed them and why they're so skimpy

SPDR S&P Pharmaceuticals ETF Rating

$40.15
-1.24 (-3.00%)
(As of 04/12/2024 ET)

SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

XPH Aggregate Rating

Moderate Buy
2.58

Holdings in XPH have an aggregate rating of Moderate Buy based on 278 analyst ratings issued in the past year covering 36 companies (90.8% of the portfolio).

XPH Aggregate Price Target

$80.30
100.00% Upside
High Prediction$114.61
Average Prediction$80.30
Low Prediction$50.76

Holdings in XPH have an aggregate price target of $80.30 and a range of $50.76 to $114.61 covering 36 companies (90.8% of the portfolio).

XPH Consensus Ratings of Holdings

Strong Buy
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
Moderate Buy
14 Moderate Buy rating(s)
Hold
7 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
1 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 36 XPH Holdings

Weight
In ETF
CompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
5.48%
Elanco Animal Health Incorporatedd stock logo
ELAN
Elanco Animal Health
$14.35
-2.7%
3 of 5 stars
2.57$16.71 16.5%7Positive News
5.14%
Catalent, Inc.d stock logo
CTLT
Catalent
$56.30
-1.1%
3 of 5 stars
2.15$52.46 -6.8%13Analyst Report
4.74%
Zoetis Inc.d stock logo
ZTS
Zoetis
$149.98
-7.8%
5 of 5 stars
3.00$224.88 49.9%7Options Volume
Analyst Revision
News Coverage
Gap Down
High Trading Volume
4.62%
Viatris Inc.d stock logo
VTRS
Viatris
$11.33
-2.1%
1 of 5 stars
1.33$11.00 -2.9%3
4.38%
Axsome Therapeutics, Inc.d stock logo
AXSM
Axsome Therapeutics
$69.15
-3.6%
4 of 5 stars
2.92$119.67 73.1%12Analyst Report
Analyst Revision
4.31%
Johnson & Johnsond stock logo
JNJ
Johnson & Johnson
$147.52
-0.9%
5 of 5 stars
2.42$177.31 20.2%12Upcoming Earnings
4.22%
Jazz Pharmaceuticals plcd stock logo
JAZZ
Jazz Pharmaceuticals
$110.58
-2.6%
5 of 5 stars
2.85$195.08 76.4%13Analyst Report
4.19%
Eli Lilly and Companyd stock logo
LLY
Eli Lilly and Company
$751.64
-1.0%
5 of 5 stars
2.84$728.05 -3.1%19Analyst Report
Analyst Revision
4.12%
Organon & Co.d stock logo
OGN
Organon & Co.
$17.45
-4.5%
5 of 5 stars
2.50$21.80 24.9%4Positive News
3.96%
Merck & Co., Inc.d stock logo
MRK
Merck & Co., Inc.
$125.74
-0.3%
5 of 5 stars
2.54$131.25 4.4%13
3.95%
Bristol-Myers Squibbd stock logo
BMY
Bristol-Myers Squibb
$48.28
-1.7%
5 of 5 stars
2.11$61.12 26.6%19Short Interest ↓
Analyst Revision
3.92%
Royalty Pharma plcd stock logo
RPRX
Royalty Pharma
$28.22
-2.9%
5 of 5 stars
3.00$46.75 65.7%4Analyst Upgrade
News Coverage
3.85%
Intra-Cellular Therapies, Inc.d stock logo
ITCI
Intra-Cellular Therapies
$65.88
-3.1%
4 of 5 stars
2.90$81.42 23.6%10Analyst Revision
News Coverage
3.85%
Perrigo Company plcd stock logo
PRGO
Perrigo
$30.32
-3.1%
5 of 5 stars
3.00$40.67 34.1%3Analyst Report
3.81%
Pfizer Inc.d stock logo
PFE
Pfizer
$25.86
-1.8%
5 of 5 stars
2.35$36.88 42.6%17Analyst Revision
2.88%
Ventyx Biosciences, Inc.d stock logo
VTYX
Ventyx Biosciences
$4.60
3 of 5 stars
2.56$21.75 372.8%9
2.73%
Revance Therapeutics, Inc.d stock logo
RVNC
Revance Therapeutics
$4.13
-7.0%
4 of 5 stars
2.50$13.75 232.9%8Short Interest ↑
News Coverage
2.04%
Harmony Biosciences Holdings, Inc.d stock logo
HRMY
Harmony Biosciences
$29.50
-5.6%
4 of 5 stars
2.50$40.63 37.7%8Analyst Report
News Coverage
2.04%
Amylyx Pharmaceuticals, Inc.d stock logo
AMLX
Amylyx Pharmaceuticals
$2.10
-8.3%
4 of 5 stars
2.25$32.67 1,455.6%8
1.77%
Pacira BioSciences, Inc.d stock logo
PCRX
Pacira BioSciences
$26.83
-1.9%
5 of 5 stars
3.00$49.50 84.5%10Analyst Report
1.65%
Amphastar Pharmaceuticals, Inc.d stock logo
AMPH
Amphastar Pharmaceuticals
$39.62
-1.3%
5 of 5 stars
2.50$66.00 66.6%4Analyst Report
News Coverage
1.58%
CymaBay Therapeutics, Inc.d stock logo
CBAY
CymaBay Therapeutics
$32.48
3 of 5 stars
2.08$28.65 -11.8%12Analyst Report
1.58%
Corcept Therapeutics Incorporatedd stock logo
CORT
Corcept Therapeutics
$23.51
-1.3%
5 of 5 stars
3.00$37.30 58.7%4Short Interest ↑
Analyst Revision
1.37%
Prestige Consumer Healthcare Inc.d stock logo
PBH
Prestige Consumer Healthcare
$68.23
-1.4%
4 of 5 stars
2.50$110.00 61.2%2Positive News
1.29%
Cassava Sciences, Inc.d stock logo
SAVA
Cassava Sciences
$22.75
-12.9%
4 of 5 stars
3.00$124.00 445.1%1Options Volume
High Trading Volume
1.06%
Supernus Pharmaceuticals, Inc.d stock logo
SUPN
Supernus Pharmaceuticals
$30.24
-5.5%
4 of 5 stars
3.00$41.00 35.6%1
1.03%
Arvinas, Inc.d stock logo
ARVN
Arvinas
$36.29
-2.6%
2 of 5 stars
2.88$59.73 64.6%16Analyst Report
Short Interest ↑
News Coverage
1.02%
Pliant Therapeutics, Inc.d stock logo
PLRX
Pliant Therapeutics
$14.15
-2.2%
4 of 5 stars
3.00$49.00 246.3%9Analyst Report
0.79%
Harrow Health, Inc.d stock logo
HROW
Harrow Health
$12.65
-4.1%
2 of 5 stars
3.00$30.35 139.9%3Analyst Report
Short Interest ↑
News Coverage
0.69%
Innoviva, Inc.d stock logo
INVA
Innoviva
$14.63
-0.5%
4 of 5 stars
3.00$22.50 53.8%1Short Interest ↓
Positive News
0.68%
Collegium Pharmaceutical, Inc.d stock logo
COLL
Collegium Pharmaceutical
$35.71
-1.9%
2 of 5 stars
2.60$39.00 9.2%5Analyst Report
News Coverage
0.60%
Ligand Pharmaceuticals Incorporatedd stock logo
LGND
Ligand Pharmaceuticals
$81.36
-0.1%
5 of 5 stars
3.00$116.33 43.0%3Analyst Report
Short Interest ↓
0.49%
Aclaris Therapeutics, Inc.d stock logo
ACRS
Aclaris Therapeutics
$1.21
-0.8%
2 of 5 stars
2.14$22.25 1,738.8%7News Coverage
0.44%
Theravance Biopharma, Inc.d stock logo
TBPH
Theravance Biopharma
$9.61
+7.6%
2 of 5 stars
3.00$20.50 113.3%2Analyst Report
News Coverage
Gap Up
0.28%
Ocular Therapeutix, Inc.d stock logo
OCUL
Ocular Therapeutix
$7.99
-3.5%
4 of 5 stars
3.00$16.80 110.3%5Short Interest ↑
0.27%
ANI Pharmaceuticals, Inc.d stock logo
ANIP
ANI Pharmaceuticals
$66.88
-1.8%
5 of 5 stars
3.00$80.00 19.6%4Short Interest ↓
This page (NYSEARCA:XPH) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners